Bryce D. Carmine
2009
In 2009, Bryce D. Carmine earned a total compensation of $8.7M as Retired Executive Vice President and President, Lilly Bio-Medicines at Lilly Eli & Co, a 28% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,776,537 |
|---|---|
| Non-Equity Incentive Plan | $1,410,750 |
| Salary | $916,667 |
| Stock Awards | $4,500,000 |
| Other | $57,001 |
| Total | $8,660,955 |
Carmine received $4.5M in stock awards, accounting for 52% of the total pay in 2009.
Carmine also received $1.8M of change in pension value and nonqualified deferred compensation earnings, $1.4M in non-equity incentive plan, $916.7K in salary and $57K in other compensation.
Rankings
In 2009, Bryce D. Carmine's compensation ranked 300th out of 9,885 executives tracked by ExecPay. In other words, Carmine earned more than 97.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 300 out of 9,885 | 97th |
Division Manufacturing | 106 out of 3,690 | 97th |
Major group Chemicals And Allied Products | 31 out of 871 | 96th |
Industry group Drugs | 26 out of 643 | 96th |
Industry Pharmaceutical Preparations | 24 out of 446 | 95th |
Source: SEC filing on March 5, 2012.
Carmine's colleagues
We found four more compensation records of executives who worked with Bryce D. Carmine at Lilly Eli & Co in 2009.